BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 26756467)

  • 1. Identification of Genes Associated with Papillary Thyroid Carcinoma (PTC) for Diagnosis by Integrated Analysis.
    Li WB; Zhou J; Xu L; Su XL; Liu Q; Pang H
    Horm Metab Res; 2016 Apr; 48(4):226-31. PubMed ID: 26756467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RNA sequencing identifies crucial genes in papillary thyroid carcinoma (PTC) progression.
    Qiu J; Zhang W; Xia Q; Liu F; Li L; Zhao S; Gao X; Zang C; Ge R; Sun Y
    Exp Mol Pathol; 2016 Feb; 100(1):151-9. PubMed ID: 26708423
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Network-based meta-analysis in the identification of biomarkers for papillary thyroid cancer.
    Zhao H; Li H
    Gene; 2018 Jun; 661():160-168. PubMed ID: 29625265
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of potential biomarkers and drugs for papillary thyroid cancer based on gene expression profile analysis.
    Qu T; Li YP; Li XH; Chen Y
    Mol Med Rep; 2016 Dec; 14(6):5041-5048. PubMed ID: 27779685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene expression profile analyze the molecular mechanism of CXCR7 regulating papillary thyroid carcinoma growth and metastasis.
    Zhang H; Teng X; Liu Z; Zhang L; Liu Z
    J Exp Clin Cancer Res; 2015 Feb; 34(1):16. PubMed ID: 25887589
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BCL2 and hsa-miR-181a-5p are potential biomarkers associated with papillary thyroid cancer based on bioinformatics analysis.
    Zhang C; Bo C; Guo L; Yu P; Miao S; Gu X
    World J Surg Oncol; 2019 Dec; 17(1):221. PubMed ID: 31842912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of biomarkers associated with cervical lymph node metastasis in papillary thyroid carcinoma: Evidence from an integrated bioinformatic analysis.
    Zhang Z; Zhao S; Wang K; Shang M; Chen Z; Yang H; Chen Y; Chen B
    Clin Hemorheol Microcirc; 2021; 78(2):117-126. PubMed ID: 33554894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microarray technology to investigate genes associated with papillary thyroid carcinoma.
    Zhu X; Yao J; Tian W
    Mol Med Rep; 2015 May; 11(5):3729-33. PubMed ID: 25586635
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of key genes and miRNAs markers of papillary thyroid cancer.
    Qiu J; Zhang W; Zang C; Liu X; Liu F; Ge R; Sun Y; Xia Q
    Biol Res; 2018 Nov; 51(1):45. PubMed ID: 30414611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Landscape of Circular RNA Expression Profiles in Papillary Thyroid Carcinoma Based on RNA Sequencing.
    Lan X; Xu J; Chen C; Zheng C; Wang J; Cao J; Zhu X; Ge M
    Cell Physiol Biochem; 2018; 47(3):1122-1132. PubMed ID: 29847813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification and analysis of genes associated with papillary thyroid carcinoma by bioinformatics methods.
    Zhang S; Wang Q; Han Q; Han H; Lu P
    Biosci Rep; 2019 Apr; 39(4):. PubMed ID: 30872410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Key genes and pathways predicted in papillary thyroid carcinoma based on bioinformatics analysis.
    Yu J; Mai W; Cui Y; Kong L
    J Endocrinol Invest; 2016 Nov; 39(11):1285-1293. PubMed ID: 27250077
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Special role of JUN in papillary thyroid carcinoma based on bioinformatics analysis.
    Chen W; Liu Q; Lv Y; Xu D; Chen W; Yu J
    World J Surg Oncol; 2017 Jul; 15(1):119. PubMed ID: 28673327
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigating the mechanisms of papillary thyroid carcinoma using transcriptome analysis.
    Qiu J; Zhang W; Xia Q; Liu F; Zhao S; Zhang K; Chen M; Zang C; Ge R; Liang D; Sun Y
    Mol Med Rep; 2017 Nov; 16(5):5954-5964. PubMed ID: 28849102
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of BRAF mutational status on expression profiles in conventional papillary thyroid carcinomas.
    Schulten HJ; Alotibi R; Al-Ahmadi A; Ata M; Karim S; Huwait E; Gari M; Al-Ghamdi K; Al-Mashat F; Al-Hamour O; Al-Qahtani MH; Al-Maghrabi J
    BMC Genomics; 2015; 16 Suppl 1(Suppl 1):S6. PubMed ID: 25922907
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification and validation of potential target genes in papillary thyroid cancer.
    Zhang K; Liu J; Li C; Peng X; Li H; Li Z
    Eur J Pharmacol; 2019 Jan; 843():217-225. PubMed ID: 30472204
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of differentially expressed genes and long non-coding RNAs in papillary thyroid carcinoma diagnosis, progression, and prognosis.
    Cai WY; Chen X; Chen LP; Li Q; Du XJ; Zhou YY
    J Cell Biochem; 2018 Nov; 119(10):8249-8259. PubMed ID: 29968931
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of differentially expressed genes and signaling pathways in papillary thyroid cancer: a study based on integrated microarray and bioinformatics analysis.
    Sun T; Guan Q; Wang Y; Qian K; Sun W; Ji Q; Wu Y; Guo K; Xiang J
    Gland Surg; 2021 Feb; 10(2):629-644. PubMed ID: 33708546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-146b: A Novel Biomarker and Therapeutic Target for Human Papillary Thyroid Cancer.
    Chou CK; Liu RT; Kang HY
    Int J Mol Sci; 2017 Mar; 18(3):. PubMed ID: 28294980
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of Key Pathways and Genes in Anaplastic Thyroid Carcinoma via Integrated Bioinformatics Analysis.
    Hu S; Liao Y; Chen L
    Med Sci Monit; 2018 Sep; 24():6438-6448. PubMed ID: 30213925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.